Clinical Trial Update: Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This document reports on a Phase 1/2 clinical trial evaluating Holmium-166 DOTMP chemotherapy combined with peripheral stem cell transplantation in patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Holmium-166 DOTMP (holmium-166 DOTMP)

Snippet

Sponsor: Poniard Pharmaceuticals | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 1, Phase 2 | Status: COMPLETED